Study on computer-assisted diabetes risk management conducts research to improve quality of diabetes care and explores the effects of Accu-Chek Mellibase, in primary care.
The primary goal is to achieve benefits for people with this disease, or at risk of developing it. Also to promote patient and public involvement.
Biopharmaceutical company established to develop new therapies that may prevent, ameliorate, or reverse diabetes and allow for the discontinuation of insulin.
Health /
Medicine /
Medical_Specialties /
Endocrinology /
Journals
|